Nukkleus Financial Statements From 2010 to 2025

NUKK Stock  USD 14.53  0.38  2.69%   
Nukkleus financial statements provide useful quarterly and yearly information to potential Nukkleus investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nukkleus financial statements helps investors assess Nukkleus' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nukkleus' valuation are summarized below:
Gross Profit
998.5 K
Profit Margin
(1.44)
Market Capitalization
67.8 M
Enterprise Value Revenue
11.9862
Revenue
5.9 M
There are currently one hundred twenty fundamental ratios for Nukkleus that can be evaluated and compared over time across peers in the industry. We recommend to check Nukkleus' last-minute fundamental drivers against the all of the trends between 2010 and 2025. The value of Market Cap is estimated to slide to about 28.4 M. The Enterprise Value is projected to slide to about 31.9 M

Nukkleus Total Revenue

6.46 Million

Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 K, Selling General Administrative of 10.4 M or Selling And Marketing Expenses of 42.4 K, as well as many indicators such as Price To Sales Ratio of 6.15, Dividend Yield of 6.0E-4 or Days Sales Outstanding of 1.85. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Nukkleus Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities2.3 M3.9 MM
Slightly volatile
Total Current Liabilities8.5 M8.1 M3.2 M
Slightly volatile
Common Stock Shares Outstanding12.3 M12.9 M148 M
Slightly volatile
Total Liabilities9.8 M9.3 M3.6 M
Slightly volatile
Common Stock22824012.8 K
Very volatile
Short and Long Term Debt Total4.8 M4.6 M1.9 M
Slightly volatile
Capital Stock17918818.8 K
Slightly volatile
Current Deferred Revenue153.5 K191.3 K91 K
Slightly volatile

Nukkleus Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization15.1 K15.9 K128 K
Pretty Stable
Selling General Administrative10.4 M9.9 M2.6 M
Slightly volatile
Selling And Marketing Expenses42.4 K40 K54.9 K
Pretty Stable
Total Revenue6.5 M6.8 M10.5 M
Slightly volatile
Other Operating Expenses15.3 M23.1 M13.2 M
Slightly volatile
Cost Of Revenue5.4 M5.7 M10.2 M
Slightly volatile
Total Operating Expenses18.3 M17.5 M5.4 M
Slightly volatile

Nukkleus Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow38.7 K40.8 K363.9 K
Slightly volatile
Change To Operating Activities4.2 MM1.4 M
Slightly volatile
Depreciation15.1 K15.9 K371 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.156.474.2 K
Slightly volatile
Dividend Yield6.0E-46.0E-47.0E-4
Slightly volatile
Days Sales Outstanding1.851.958.6904
Very volatile
Average Payables211.8 K201.7 K69.7 K
Slightly volatile
Stock Based Compensation To Revenue0.04240.04470.467
Slightly volatile
EV To Sales6.897.254.2 K
Slightly volatile
Payables Turnover9.379.87183
Very volatile
Sales General And Administrative To Revenue1.341.672.2806
Slightly volatile
Cash Per Share0.03740.03880.0353
Slightly volatile
Days Payables Outstanding36.3738.2955.9728
Slightly volatile
Intangibles To Total Assets0.02140.02250.5946
Slightly volatile
Current Ratio0.150.161.9879
Slightly volatile
Receivables Turnover1841942.8 K
Slightly volatile
Average Receivables14 K15.8 K17.2 K
Slightly volatile
Revenue Per Share0.350.371.3751
Pretty Stable
Interest Debt Per Share0.140.290.1914
Slightly volatile
Debt To Assets3.843.661.4656
Slightly volatile
Days Of Payables Outstanding36.3738.2955.9728
Slightly volatile
Ebt Per Ebit1.10.690.9947
Slightly volatile
Quick Ratio0.150.162.0765
Slightly volatile
Net Income Per E B T0.860.90.9963
Very volatile
Cash Ratio6.0E-46.0E-41.3238
Slightly volatile
Days Of Sales Outstanding1.851.958.6904
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.091.1525.8906
Slightly volatile
Debt Ratio3.843.661.4656
Slightly volatile
Price Sales Ratio6.156.474.2 K
Slightly volatile
Asset Turnover6.566.914.8747
Very volatile

Nukkleus Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap28.4 M29.9 M304.7 M
Very volatile
Enterprise Value31.9 M33.5 M305.9 M
Very volatile

Nukkleus Fundamental Market Drivers

Cash And Short Term Investments619 K

About Nukkleus Financial Statements

Nukkleus investors utilize fundamental indicators, such as revenue or net income, to predict how Nukkleus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue191.3 K153.5 K
Total Revenue6.8 M6.5 M
Cost Of Revenue5.7 M5.4 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 1.67  1.34 
Revenue Per Share 0.37  0.35 
Ebit Per Revenue(2.16)(2.27)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(39.44)
Revenue Per Share
3.422
Quarterly Revenue Growth
(0.95)
Return On Assets
(3.97)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.